News

KALA BIO Secures $6 Million Funding with David E. Lazar

KALA BIO Secures $6 Million Funding with David E. Lazar

Introduction to KALA BIO's Recent Funding Agreement

In an exciting development from KALA BIO, Inc. (NASDAQ: KALA), the clinical-stage biopharmaceutical company has announced a notable $6 million securities purchase agreement with the private investor David E. Lazar. This agreement underscores KALA BIO's commitment to innovating therapies tailored for rare and serious ocular diseases.

Details of the Securities Purchase Agreement

The agreement allows Mr. Lazar to purchase the company's non-voting convertible preferred stock. KALA BIO received an initial investment of $1.8 million from Lazar in the first closing under this agreement. With this investment, Mr. Lazar has stepped into the role of KALA's Chief Executive Officer and Chairman of the Board, while former CEO Todd Bazemore remains a member of the Board, ensuring stability during this leadership transition.

Impact of Recent Clinical Trial Results

Earlier in the year, KALA announced outcomes from its Phase 2b clinical trial for KPI-012, aimed at treating persistent corneal epithelial defect (PCED). Unfortunately, the trial did not meet its primary endpoint related to complete healing of PCED, raising critical questions about the treatment's efficacy. This situation led KALA to halt development temporarily while seeking strategic options.

Continuing Development and Strategic Exploration

In light of the fresh investment from Mr. Lazar, KALA BIO plans to revisit the redevelopment of its therapeutic candidates. This pivot demonstrates KALA's resilience and adaptability in navigating the challenges encountered during clinical trials. Additionally, the company might consider assessing its product candidates for both standalone applications and in combination with other treatments.

The Vision of David E. Lazar

David Lazar expressed enthusiasm about this investment, emphasizing his commitment to both evaluating and redeveloping KALA's product candidates. He believes that this agreement should foster growth opportunities that significantly enhance shareholder value. Lazar's proven track record, particularly in capital restructuring and reverse mergers, positions him as an asset to steer KALA through this pivotal phase.

Future Prospects Following the Agreement

KALA’s decision to engage in this transaction follows comprehensive reviews by its Board, aiming to maximize shareholder value. The company's focus remains on advancing its projects while exploring diverse avenues for strategic development. During the first quarter of the upcoming year, KALA expects shareholder meetings to finalize plans regarding stockholder approvals for the second closing, consisting of an additional $4.2 million investment in non-voting convertible preferred stock.

About KALA BIO, Inc.

KALA BIO is dedicated to developing unique therapies for severe ocular diseases through its proprietary mesenchymal stem cell secretome (MSC-S) platform. Its flagship product, KPI-012, highlights the innovative use of biologics to deliver essential biofactors crucial for corneal healing. Recognized with Orphan Drug and Fast Track designations by the U.S. FDA, KPI-012 represents a significant hopeful alternative for patients suffering from PCED.

Get in Touch with KALA BIO

If you need further information or wish to reach out, you can contact David Lazar, the Chief Executive Officer and Chairman of the Board, at his email: david@activistinvestingllc.com.

Frequently Asked Questions

What is the significance of KALA BIO's agreement with David E. Lazar?

This agreement provides KALA BIO with $6 million in funding to continue the development of its eye disease therapies, aiming to enhance shareholder value.

What were the results of KALA's recent clinical trial?

The Phase 2b trial for KPI-012 did not meet its primary endpoint for healing PCED, prompting KALA to reassess its development strategy.

Who is David E. Lazar?

David E. Lazar is a private investor who has been appointed as KALA's CEO and Chairman, bringing his expertise in capital restructuring.

What are KALA's future plans following the recent investment?

KALA BIO intends to redevelop its product candidates and explore strategic opportunities to diversify its therapeutic applications.

How can I reach KALA BIO for more information?

You can contact CEO David Lazar directly via email at david@activistinvestingllc.com for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 2

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 4

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 3

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 42

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 3

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 4

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 2

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 1

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading

Top 5 Most Recently Viewed Articles

Russell Investments Canada Limited Reveals ETF Monthly Payouts

Updated Category News Views 159

Russell Investments Canada Limited Announces Cash Distributions Russell Investments Canada Limited today unveiled the cash distributions for the ETF Series of selected mutual funds for December 2024. The unitholders recorded as of the specified Record Date will receive the announced cash distribution per unit on the established Payment Date. Details of the ETF...

Continue Reading
EBANX Takes Significant Steps in Global Digital Payment Expansion

Updated Category News Views 150

EBANX Enhances Global Payment Operations EBANX, a renowned global Payment Service Provider (PSP) dedicated to emerging markets, has achieved a pivotal milestone by securing In-Principle Approval for a Major Payment Institution (MPI) license from the Monetary Authority of Singapore. This crucial approval not only bolsters EBANX's operational framework within the...

Continue Reading
Arcadis Q3 2024 Update: Major Wins Fuel Growth and Margins

Updated Category News Views 102

Arcadis Q3 2024 Update Highlights Arcadis has released its trading update for the third quarter of 2024, showcasing impressive growth driven by significant project wins and solid revenue generation. Key Financial Performance Metrics This quarter proved to be transformative for Arcadis, with a notable order intake of €1.3 billion, representing a remarkable 50%...

Continue Reading
FS8 Expands its Reach with New Studios and Community Focus

Updated Category News Views 264

FS8 Expands its Reach with New Studios and Community Focus With recent studio openings and a vibrant brand campaign, FS8 is dedicated to growing its presence and creating community connections. This expansion is aimed at introducing more individuals to their innovative fitness classes combining Pilates, Tone, and Yoga. As FS8 continues to flourish, it's laying down a...

Continue Reading
BIO-key International to Join H.C. Wainwright Conference

Updated Category News Views 119

BIO-key International to Participate in H.C. Wainwright Conference BIO-key International, Inc. (NASDAQ: BKYI), a leading provider of innovative Identity and Access Management (IAM) software for both workforce and customer applications, is set to take part in H.C. Wainwright’s 26th Annual Hybrid Global Investment Conference. This event will take place on September 9th...

Continue Reading